华统股份(002840) - 2023 Q3 - 季度财报
Huatong MeatHuatong Meat(SZ:002840)2023-10-30 16:00

Financial Performance - Total revenue for Q3 2023 was ¥2,045,641,525.14, a decrease of 20.13% year-over-year [22] - Net profit attributable to shareholders for Q3 2023 was -¥1,905,798.34, a decline of 101.82% compared to the same period last year [22] - Basic earnings per share for Q3 2023 was -¥0.60, representing a decrease of 100.00% year-over-year [22] - Total operating revenue for the current period is approximately ¥6.16 billion, a decrease of 3.98% from ¥6.42 billion in the previous period [41] - Net profit for the current period is approximately -¥396.31 million, compared to a net profit of ¥61.07 million in the previous period, indicating a significant decline [42] Assets and Liabilities - Total assets at the end of Q3 2023 were ¥8,972,178,554.88, an increase of 1.13% from the end of the previous year [9] - The total liabilities increased to ¥6,469,967,963.24 from ¥5,526,064,893.72, marking a rise of approximately 17.09% [64] - Non-current liabilities rose to ¥3,393,040,304.14 from ¥2,734,363,212.85, representing an increase of about 24.14% [64] - The company's equity attributable to shareholders decreased to ¥2,314,692,301.24 from ¥2,673,719,435.95, a decline of about 13.41% [64] Cash Flow - The net cash flow from operating activities for the year-to-date was ¥197,749,393.54, an increase of 20.25% [22] - Cash flow from operating activities generated a net amount of ¥197,749,393.54, compared to ¥164,450,567.20 in the previous period, indicating a growth of approximately 20.19% [72] - Cash flow from investing activities showed a net outflow of ¥777,433,106.79, compared to a net outflow of ¥872,712,608.49 in the previous period, improving by approximately 10.91% [72] - Cash flow from financing activities generated a net amount of ¥207,936,193.25, down from ¥1,500,075,504.30, a decrease of about 86.06% [72] Research and Development - Research and development expenses increased by 38.76% to ¥32,029,675.09, attributed to the increase in R&D projects [27] - The company incurred research and development expenses of approximately ¥32.03 million, an increase of 38.8% from ¥23.08 million in the previous period [41] Shareholder Equity and Incentives - Shareholders' equity attributable to the parent company decreased by 13.43% to ¥2,314,692,301.24 compared to the end of the previous year [9] - The company plans to issue A-shares to specific investors as approved in the board meetings held on July 17 and August 3, 2023 [30] - The company granted 715,200 restricted shares at a price of CNY 8.53 per share to 86 incentive targets on January 18, 2023 [33] - On September 21, 2023, the company approved the grant of 124,800 reserved restricted shares at a price of CNY 7.30 per share to 19 incentive targets [34] Other Financial Metrics - Other income increased by 71.95% to ¥103,574,074.37, mainly due to increased government subsidies [27] - The company reported a substantial increase in asset impairment losses, totaling approximately -¥100.39 million, compared to a gain of ¥75.66 million in the previous period [42] - The company reported an investment income of approximately ¥1.23 million, recovering from a loss of ¥2.40 million in the previous period [41] - The company experienced a significant increase in tax and additional fees, totaling approximately ¥14.71 million, compared to ¥10.69 million in the previous period [41]